K. Viel

519 total citations
14 papers, 393 citations indexed

About

K. Viel is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Biochemistry. According to data from OpenAlex, K. Viel has authored 14 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Physiology and 2 papers in Biochemistry. Recurrent topics in K. Viel's work include Asthma and respiratory diseases (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Cystic Fibrosis Research Advances (4 papers). K. Viel is often cited by papers focused on Asthma and respiratory diseases (8 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers) and Cystic Fibrosis Research Advances (4 papers). K. Viel collaborates with scholars based in Germany, United Kingdom and United States. K. Viel's co-authors include Steven Kesten, Klaus F. Rabe, Wolfgang Timmer, Alexandros Sagkriotis, Paul Jones, Tom Wilkinson, Gavin C. Donaldson, Jadwiga A. Wedzicha, Joachim Bargon and Nurlan Dauletbaev and has published in prestigious journals such as CHEST Journal, European Respiratory Journal and Clinical Pharmacology & Therapeutics.

In The Last Decade

K. Viel

13 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Viel Germany	10	336	287	28	14	13	14	393
Mark I. Allenby United Kingdom	6	210 0.6×	101 0.4×	23 0.8×	10 0.7×	9 0.7×	17	257
Zev M. Munk United States	11	241 0.7×	338 1.2×	12 0.4×	9 0.6×	15 1.2×	14	410
Jan Verhaert Belgium	5	495 1.5×	413 1.4×	9 0.3×	14 1.0×	4 0.3×	6	526
Laura Padullés Spain	7	258 0.8×	172 0.6×	37 1.3×	14 1.0×	15 1.2×	17	311
Ching Kong Loo China	6	113 0.3×	45 0.2×	10 0.4×	31 2.2×	38 2.9×	8	193
Nicoletta M. Azzolin Italy	8	512 1.5×	581 2.0×	9 0.3×	12 0.9×	25 1.9×	10	671
A Corrias Italy	9	75 0.2×	121 0.4×	21 0.8×	3 0.2×	4 0.3×	17	272
Jessica Tan Singapore	8	116 0.3×	82 0.3×	8 0.3×	7 0.5×	13 1.0×	18	157
Ryo Itotani Japan	8	173 0.5×	95 0.3×	9 0.3×	6 0.4×	18 1.4×	23	251
J. B. Wilk United States	3	84 0.3×	51 0.2×	21 0.8×	20 1.4×	5 0.4×	3	141

Countries citing papers authored by K. Viel

Since Specialization

Citations

This map shows the geographic impact of K. Viel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Viel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Viel more than expected).

Fields of papers citing papers by K. Viel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Viel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Viel. The network helps show where K. Viel may publish in the future.

Co-authorship network of co-authors of K. Viel

This figure shows the co-authorship network connecting the top 25 collaborators of K. Viel. A scholar is included among the top collaborators of K. Viel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Viel. K. Viel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Corriol‐Rohou, Solange, Marta del Álamo, Mathieu Boudes, et al.. (2024). The Rare Disease Moonshot: Paradigms Shift, Translational Medicine, and Regulatory Science for the World's Rarest Conditions. Clinical Pharmacology & Therapeutics. 116(6). 1387–1390.

2.

Halpin, David, Shailendra Menjoge, & K. Viel. (2009). Patient-level pooled analysis of the effect of tiotropium on COPD exacerbations and related hospitalisations. Primary Care Respiratory Journal. 18(2). 106–113. 17 indexed citations

3.

Rabe, Klaus F., Wolfgang Timmer, Alexandros Sagkriotis, & K. Viel. (2008). Comparison of a Combination of Tiotropium Plus Formoterol to Salmeterol Plus Fluticasone in Moderate COPD. CHEST Journal. 134(2). 255–262. 91 indexed citations

4.

Wilkinson, Tom, et al.. (2008). Efeito do tiotrópio na expectoração e nos marcadores inflamatórios séricos e exacerbações da DPCO. Revista Portuguesa de Pneumologia. 14(4). 573–576. 2 indexed citations

5.

Wilkinson, Tom, et al.. (2008). Efeito do tiotrópio na expectoração e nos marcadores inflamatórios séricos e exacerbações da DPCO. Revista Portuguesa de Pneumologia. 14(4). 573–576. 1 indexed citations

6.

Wilkinson, Tom, Gavin C. Donaldson, Paul Jones, et al.. (2007). Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. European Respiratory Journal. 30(3). 472–478. 140 indexed citations

7.

Hodder, Richard V., Steven Kesten, Shailendra Menjoge, & K. Viel. (2007). Outcomes in COPD patients receiving tiotropium or salmeterol plus treatment with inhaled corticosteroids.. PubMed. 2(2). 157–67. 24 indexed citations

8.

Dauletbaev, Nurlan, et al.. (2005). Antioxidant properties of cystic fibrosis sputum. American Journal of Physiology-Lung Cellular and Molecular Physiology. 288(5). L903–L909. 11 indexed citations

9.

Dauletbaev, Nurlan, K. Viel, Roland Buhl, Thomas Wagner, & Joachim Bargon. (2004). Glutathione and glutathione peroxidase in sputum samples of adult patients with cystic fibrosis. Journal of Cystic Fibrosis. 3(2). 119–124. 25 indexed citations

10.

Dietrich, C., K. Viel, Barbara Braden, W. F. Caspary, & S Zeuzem. (2000). Mediastinale Lymphadenopathie: Eine extrahepatische Manifestation der chronischen Hepatitis C?*. Zeitschrift für Gastroenterologie. 38(2). 143–152. 10 indexed citations

11.

Kirchner, Johannes, Andrea L. Stein, K. Viel, et al.. (1999). Pulmonary lymphangioleiomyomatosis: high-resolution CT findings. European Radiology. 9(1). 49–54. 32 indexed citations

12.

Dauletbaev, Nurlan, K. Viel, Jürgen Behr, et al.. (1999). Effects of short-term inhaled fluticasone on oxidative burst of sputum cells in cystic fibrosis patients. European Respiratory Journal. 14(5). 1150–1155. 23 indexed citations

13.

Bargon, Joachim, K. Viel, Nurlan Dauletbaev, Rainer Wiewrodt, & Roland Buhl. (1997). Short-term effects of regular salmeterol treatment on adult cystic fibrosis patients. European Respiratory Journal. 10(10). 2307–2311. 16 indexed citations

14.

Stein, Annette, et al.. (1997). [Hamman-Rich syndrome in a goldsmith].. PubMed. 7(6). 321–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact